Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis  by Webb, Ginette R. et al.
Osteoarthritis and Cartilage (1997) 5, 427 437 
i 1997 Osteoarthritis Research Society 1063 4584/97/060427 + 11 $12.00/0 
OSTEOARTHRITIS 
and 
CARTILAGE 
Chondrocyte tumor necrosis factor receptors and focal loss of 
cartilage in osteoarthrit is 
BY GINETTE R. WEBB, CAROLE I. WESTACOTT AND CHRISTOPHER J. ELSON 
Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, 
Bristol, U.K. 
Summary 
Objective: Osteoarthritis (OA) is characterized by focal loss of cartilage. Here we show for the first time that tumor 
necrosis factor (TNF) ~ can act on cartilage but only at specific sites where chondrocyte TNF~-receptor (R) expression 
is high. 
Design: Cartilage xplants from specified sites in the knee joints of both OA patients and non-arthritic (NA) subjects 
were cultured with and without TNFct for 14 days and cumulative glycosaminoglycan (GAG) release into the 
supernatant measured, p55 and p75 TNF-R expression was measured by flow cytometry on chondrocytes i olated 
from the same sites. 
Results: Cartilage xplants from different sites in knee joints from both OA patients and NA subjects varied in their 
susceptibility to TNF~. Overall, the proportion of samples that responded to TNFct was higher in cartilage taken from 
OA joints than cartilage from NA subjects. Variations in p55 and p75 TNF-R expression were found between 
chondrocytes from different sites, p55, but not p75 TNF-R, expression on chondrocytes was closely related to the 
susceptibility of explants from the same site to TNF~dnduced GAG loss. 
Conclusion: It is considered that focal loss of cartilage will occur at sites where chondrocyte p55 TNF-R expression 
is high, if sufficient TNF~. is present, and that these results identify a mechanism by which cytokine-mediated focal 
loss of cartilage may occur. 
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Introduction 
DEGRADATION of cart i lage matr ix and the eventual  
loss of functional joint cart i lage are features of 
both osteoarthr it is  (OA) and rheumatoid arthr it is  
(RA), a l though the anatomical  distr ibution of 
such loss differs between the two diseases. Since 
the discovery by Fell and Jubb of a factor from 
porcine cart i lage which st imulated chondrocytes 
to degrade cart i lage [1] and its subsequent 
character izat ion as the cytokine interleukin-1 
(IL-1) [2, 3], attent ion has focused on the possible 
role of cytokines in these diseases. It is now 
general ly accepted that locally produced cyto- 
kines, part icular ly IL-1 and tumor necrosis factor 
(TNF) ~ are major  st imulants of cart i lage 
degradat ion in RA. This view is based on the fact 
that  IL-I and TNF~ are produced spontaneously 
by RA synovium [4-6], and that  both cytokines 
can degrade animal carti lage in vitro [7, 8] and 
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in vivo [9, 10]. Despite the latter reports it remains 
to be establ ished whether  cart i lage catabol ic 
cytokines contr ibute to the process that  leads 
to loss of cart i lage in OA, a l though some 
observations lend credence to this theory. For 
example, cells from OA synovium produce higher 
amounts of IL-I~ [11] than normal  synovium, TNF~ 
is secreted by OA synovium [12], and both these 
cytokines have been detected in synovial  fluid from 
OA patients [13-15]. In addition, the overal l  
act ivity of cart i lage-degrading enzymes, known 
to be produced by chondrocytes in response to 
st imulat ion by IL-1 or TNF~, is increased in OA 
[16]. However, a major  difficulty for the cytokine 
theory is to explain how cart i lage is lost only at 
part icular  anatomical  sites, i.e., how can cytokines 
mediate focal loss of cart i lage in OA? 
We showed some years ago that  OA cart i lage 
explants appeared to be more susceptible to the 
degradative ffects of IL-1 [17] and TNF~ [18] than 
nonarthr i t ic  (NA) carti lage. We also showed that  
OA chondrocytes expressed more of the signal 
t ransducing p55 TNF-R than NA chondrocytes [19] 
whilst others provided evidence that type I IL-1R 
expression is increased on OA chondrocytes [20]. 
Increased susceptibi l i ty to cytokine- induced 
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degradation thus appears to be associated with 
increased cytokine receptor expression. If so, these 
results suggest hat for cartilage degradation to 
occur, not only must the cytokines be present, but 
the cartilage must be susceptible to their effects. 
To explain how TNF~ contributes to the focal loss 
of cartilage in OA this hypothesis predicts that 
cartilage from different anatomical sites in joints 
varies both in its susceptibility to TNF~-induced 
GAG loss and in the levels of chondrocyte TNF-R 
they express. Moreover, a relationship should exist 
between chondrocyte p55 TNF-R expression and 
the susceptibility ofexplants from the same area to 
TNFuinduced GAG loss. The purpose of this work 
was to determine whether or not these predictions 
are satisfied. Accordingly, this paper describes 
experiments in which TNF-R expression on 
chondrocytes from human articular cartilage at 
six anatomical sites on femoral condyles was 
measured and related to the susceptibility of 
the remaining explant portion to TNF~-induced 
degradation. 
Mater ia ls  and Methods  
CARTILAGE 
Cartilage was obtained less than 6h post- 
operatively from specific anatomical regions of 
the knee joints (Fig. 1) of OA patients undergoing 
surgery for total knee replacement (N=8; four 
female and four male, mean age 66 • 10.3 years, 
range 43-75 years). Details of joint damage were 
diagramatically recorded: the cartilage on seven 
OA knees was damaged on the medial femoral 
condyle, whilst cartilage on the lateral side was 
lnacroscopically normal. Cartilage on one OA knee 
was damaged on the lateral condyle, whilst the 
medial side was intact. Cartilage was obtained less 
than 48 h post-mortem from the same regions of NA 
knee joints (N= 3, two female, one male, mean age 
69 • 7.6 years, range 62-77 years) in patients with 
no clinical evidence of arthritis. This cartilage 
was macroscopically normal. Full-depth cartilage 
slices were removed, where available, under sterile 
conditions using a scapel, washed twice in 
phosphate-buffered saline (PBS) and semi-circular 
biopsies cut using a 3 mm diameter biopsy punch. 
CHONDROCYTE ISOLATION AND STAINING 
For each region, offcuts from biopsied cartilage 
slices were finely chopped into cubes (2 3 mm 2) and 
the chondrocytes released by sequential enzymatic 
digestion, as previously described [19]. The 
resulting digest was filtered (40 pm, Falcon) to 
remove any debris and the chondrocytes washed 
in HAMS F12 medium supplemented with 2 mM 
L-Glutamine, 100 U/ml penicillin, 100 pg/ml strep- 
tomycin, 25 mM HEPES and 10% fetal calf serum 
(FCS) (Complete HAMS). The viability of both the 
OA and NA chondrocytes as assessed by trypan 
blue exclusion was 91.4 • 5.5% (range 78.7-99). 
To allow the TNF-Rs to return to pre-treatment 
levels [21, 22], chondrocytes were rested for 16 h 
(37~ 5% CO2) in flasks coated with 2% agarose 
(Type VII, Sigma) [19]. Next the chondrocytes were 
washed twice in 2M sodium chloride/20mM 
HEPES buffer (pH 7.4) and once in 2 M sodium 
chloride/20 mM sodium acetate (pH 4) to remove 
any bound ligand [19]. The viability of the 
chondrocytes was assessed again and was 
73 • 12%. U937 cells, a monocytic ell line known 
to express TNF-R [23], were used as a positive 
control; Raji cells, a B-cell line reported not to 
express TNF-R [24], was used to determine 
nonspecific binding [25]. The chondrocytes and 
control cells were stained for p55 and p75 TNF-R 
expression using noncross-reacting antibodies [25] 
and analyzed by flow cytometry, as previously 
described [19]. Briefly, chondrocytes and control 
cells (5x105/25 pl) were incubated (45 rain, 4~ 
with mouse monoclonal antibodies (kind gift of 
Dr M. Brockhaus, Hoffman La Roche, Basel) to 
either the p55 receptor (htr9), the p75 receptor 
(utrl), or with IgG~ isotype control (Becton 
Dickinson). All cells were washed and incubated 
(15 min, 4~ with goat anti-mouse IgG conjugated 
to flourescein-isothiocyanate (Dako). The cells 
were then washed and resuspended in 250~d 
of PBS/0.25% formaldehyde prior to analysis 
(FACScan, Becton Dickinson). Comparison was 
made between cells stained with specific mono- 
clonal antibodies and cells from the same 
population stained with the appropriate isotype 
control. Results were calculated by determining 
the shift in fluorescence of the test population 
compared with control and expressed as the 
proportion of positive cells in the population 
analyzed (5000 cells). The reproducibility of the 
calculation of the percentage xpression, the 
co-efficient of variance (CV), was 8.9 _+ 0.8% and 
the limit of detection 2%. 
To estimate the number of receptors per cell, 
beads exhibiting various numbers of mouse IgG 
molecules (Dako, Qifi-kit) were incubated, at 
the same time as cells, with fluorescein-labelled 
goat anti-mouse IgG. A standard curve of mean 
fluorescence intensity against antigen density was 
constructed using the beads. The net fluorescence 
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intensity of the chondrocytes run at the same 
setting was measured. The relative receptor 
number on the chondrocytes (which is directly 
proportional to the antigen density) was calcu- 
lated from the standard curve. The reproducibility 
of the estimation of receptor number per chondro- 
cyte (CV) was 8.7 _+ 1.0% and the limit of detection 
100 TNF-R per chondrocyte. 
CULTURE OF CARTILAGE WITH TNFz. 
Six biopsies were taken from each region. 
To minimize variance ach biopsy was cut in half 
and the two pieces placed in separate wells of 
a 48-well plate (Costar). One half of each biopsy 
was cultured in 1 ml RPMI supplemented with 
5% normal human serum, 2mM L-glutamine, 
100 U/ml penicillin, 100 gg/ml streptomycin, and 
25 mM HEPES (complete RPMI), and 10 ng rhTNF~ 
(Kind gift of Dr G.R. Adolf, Bender, Vienna). 
The corresponding (control) halves were cultured 
in 1 ml complete RPMI alone. The biopsies were 
cultured for 14 days (37~ 5% CO2) and the media 
changed every 2 days. The culture supernatants 
from each time point were collected and stored 
at -20~ At the end of the culture period each 
half biopsy was removed, dried in an oven (37~ 
1 week) and weighed. 
The effect of TNF~ on cartilage matrix was 
determined by measuring GAG released from the 
biopsy into the supernatant using the colorimetric 
method of Farndale [26]. The GAG content of the 
supernatants were adjusted for dry weight of 
biopsy and expressed as micrograms per milligram 
of cartilage. For cumulative GAG release from 
each half biopsy, the concentration of GAG 
released into the supernatants obtained at differ- 
ent time points were summated. Comparison was 
made between GAG release from cartilage cultured 
in the presence of TNF~ and GAG release from 
cartilage cultured in RPMI alone. The results are 
expressed as percentage increase in GAG release, 
% increase = ~ (Testc_ontr~]_- Control) xl00. 
STAT IST ICAL  ANALYS IS  
For the six biopsies from each region the 
Student's paired t-test was used to compare the 
difference in the amount of GAG released from 
the half cartilage biopsy cultured in the presence 
of TNF~ with the corresponding control half 
cultured in medium. The difference in the 
proportion of OA and NA cartilage explants 
responding to TNFc( was examined by X 2 test. 
Correlations between TNF-R expression and per 
cent increase in GAG release were assessed using 
Spearman's rank correlation co-efficient. P _< 0.05 
was taken as significant. 
Results  
To determine if cartilage from different regions 
within the knee joint varies in its response to 
TNFu cartilage was taken from different regions of 
the knee (Fig. 1), the explants cultured in the 
presence and absence of TNFc~ for 14 days and the 
total amount of GAG released into the supernatant 
measured. Fig. 2 details the results of experiments 
using explants from five OA [(a)-(e)] and three NA 
[(f)-(h)] patients. First, variation within patients 
can be seen in TNF~-induced GAG release from 
cartilage isolated from different regions of the 
knee. For example, the amount of GAG released 
by TNFc~ treated explants from regions 1, 3 and 
4 of cartilage from patient a [Fig. 2(a)] were 
significantly higher than their untreated controls 
(60, 100 and 50% respectively). By contrast, 
insignificant amounts of GAG were released by 
explants from regions 2 and 6. Similarly, the 
amount of GAG released by explants from regions 
1 and 5 of cartilage from NA subject (f) [Fig. 2(f)] 
were significantly higher than their controls 
(40, and 50% respectively) whereas insignificant 
amounts of GAG were released by explants from 
regions 2, 3 and 4. 
Second, it can be seen that there was some 
variation in susceptibility to TNF~ between 
explants from the same region in knees from 
FIG. 1. Diagram of the different anatomical regions of 
the knee joint from which cartilage was obtained. 
Regions 1, 2 and 3 were located on the lateral femoral 
condyle, regions 4, 5 and 6 on the medial femoral 
condyle. Regions 1 and 4 were located at the anterior, 
regions 3 and 6 at the posterior aspects of the knee joint. 
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FIG. 2. Effect of TNF~ on percentage GAG release during 14 days of culture from cart i lage explants taken from specific 
anatomical  regions of five OA knees, pat ients a, b, c, d and e, and three NA knees, pat ient f, g, and h. All  values are 
the mean • SEM of six replicates. ND (not done) denotes regions where insufficient cart i lage was avai lable.  Signif icant 
increase in TNFa induced GAG release as compared with control  is indicated by **P < 0.01 and *P < 0.05 (paired 
t-test). 
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different patients (compare regions 2, 3, 4 and 6 in 
patients a-h). Even in regions which were 
susceptible to TNF~, the amount of GAG released 
as a proportion of the control varied (compare 
region 3 in patients a-e). Similar variations were 
observed with another three OA knees (results not 
shown). 
The data in Fig. 2 shows the cumulative GAG 
released during 14 days of culture. The time 
required before a significant increase in GAG 
release was seen differed between regions and 
between patients. However, those explants which 
showed an early response to TNF~. generally 
exhibited the greatest cumulative GAG loss by 
day 14. For example, (Fig. 3) in the joint removed 
from patient e, explants isolated from region 2 did 
not exhibit significant GAG release until day 10, 
whereas GAG release fi'om region 6 reached 
significance after only 4 days. 
Are explants from OA patients more susceptible 
to TNF-induced GAG loss than those from NA 
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FIG. 3. TNF~ induced cumulative GAG release from 
cartilage xplants of patient c(a) region 2 and (b) region 
6 over 14 days. Solid bars represent explants cultured 
with TNF~ and open bars explants cultured in medium 
alone. Significant increase in TNF~. induced GAG 
release as compared with control is indicated by 
**P < 0.01 and *P < 0.05 (paired t-test). 
subjects? Of the 33 areas sampled (six biopsies 
per sample) from specific regions of the OA 
knees, 25 (75.8%) exhibited significantly increased 
GAG loss in the presence of TNFa as compared 
with untreated controls. By contrast, only five 
of t5 areas sampled (33.3%) from different 
regions of the NA knees showed a significant 
TNF-induced increase in GAG loss as compared 
with untreated controls. The difference between 
the proportion of OA and NA explants responding 
to TNFa was significant (P < 0.01) as judged by 
the Z 2 test. 
CHONDROCYTES TNF-R EXPRESSION 
Experiments were performed to determine if 
there were also regional differences in the 
proportion of chondrocytes xpressing TNF-R and 
the number of TNF-R expressed per chondrocyte. 
Accordingly, chondrocytes released from cartilage 
taken from the specified regions were stained for 
p55 and p75 TNF-R expression. It was found that 
both the proportion of chondrocytes expressing 
p55 TNF-R (Fig. 4) and the number of p55 TNF-R 
per chondrocyte (Fig. 5) differed between regions. 
For example, from Fig. 4(a) it is evident hat 19 
and 22% of chondrocytes i olated from regions 1 
and 4, respectively, expressed the p55 TNF-R. By 
contrast, Iess than 4% of chondrocytes i olated 
from region 2 expressed the p55 TNF-R. Similarly, 
[Fig. 5(a)] chondrocytes i olated from regions 1 
and 4 expressed between 4000 and 5000 p55 
TNF-R/chondrocyte, whilst those from region 2 
expressed less than 1000, and from region 3 and 
6 expressed between 2000 and 3000 p55 TNF-R. 
Similar variations in TNF-R expression on chon- 
drocytes isolated from different regions of NA 
knees were also found [Fig. 4 and Fig. 5(f-h)] To 
determine whether the variability in chondrocyte 
p55 TNF-R expression could be attributed to cell 
viability immediately before analysis, a correlation 
was sought between the two parameters. No 
relationship was found for either proportion or 
receptor number (RS=0.19, N=48, P=0.35 and 
RS 0.28, N= 48, P= 0.17), respectively. A statistical 
analysis was performed to determine whether the 
number of p55 TNF-R/chondrocyte was related to 
the proportion of chondrocytes expressing p55 
TNF-R. A positive correlation (RS=0.91, N=48, 
P < 0.001) was demonstrated. 
As illustrated in Fig. 6 the proportion of 
chondrocytes expressing p75 TNF-R and the 
number of p75 TNF-R per chondrocyte again 
varied between different regions of the knee. 
However, chondrocyte p75 TNF-R expression was 
at or below the detection limit of the assay in many 
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regions and in some subjects (one OA and two NA) 
was at or below the detection limit in all regions 
(results not shown). A positive, although weak, 
correlat ion was found between the proport ion 
of chondrocytes expressing p55 and p75 TNF-R 
RS = 0.51, N= 48, P < 0.001) and also between the 
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number of p55 and p75 TNF-R/chondrocyte 
(RS = 0.47, N= 48, P < 0.001). 
TNF-R  EXPRESS ION AND CART ILAGE DEGRADATION 
If the variable response of carti lage explants 
to TNF~ is due to the differential expression of 
functional p55 or p75 TNF-R then the amount of 
GAG released from the explants should be related 
to chondrocyte TNF-R expression. Fig. 7 shows 
that such relationships exist. Both the proport ion 
of chondrocytes expressing p55 TNF-R and the 
number of p55 TNF-R/chondrocyte correlated with 
TNF-induced GAG loss from carti lage explants. 
A significant relationship between these par- 
ameters was demonstrated whether OA and NA 
data were analyzed separately or combined. By 
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FIG. 7. Relationship between (a) cumulative TNF~ 
induced GAG release after 14 days of culture and the 
proportion of chondrocytes expressing p55 TNF-R 
(RS=0.71, P<0.001, N=48; OA RS=0.54, P=0.002, 
N= 32; NA RS = 0.92, P < 0.001, N= 16) and (b) cumulat- 
ive TNF~ induced GAG release after 14 days of culture 
and the relative number of p55 TNF-R/chondrocyte. 
(RS=0.75, P<0.001, N=48; OA RS=0.62, P<0.001, 
N= 32; NA RS=0.86, P < 0.001, N= 16.) Closed circles 
represent explants from OA patients and open circles 
explants from NA subjects. 
contrast no relationship was found between either 
the proport ion of chondroctes expressing p75 
TNF-R (RS = 0.12, N= 48, P = 0.4) or the number of 
p75 TNF-R/chondrocyte (RS = 0.15 N= 48, P = 0.33) 
and TNF-induced GAG loss from carti lage 
explants. 
Discussion 
These results show, for the first time, that  the 
susceptibil ity of carti lage explants from different 
sites within the knee joints of OA patients and NA 
subjects varies in their response to TNF~ as judged 
by TNF~-induced GAG loss. It is known that the 
superficial layers of normal human art icular 
carti lage are more susceptible to st imulation by 
IL-1 than the deeper layers [27]. If the same is true 
for TNF~, then it could be argued that for the 
carti lage from OA patients the observed regional 
variat ion results from the variable loss of the 
superficial zone at different sites. Since the zone 
most susceptible to catabolic cytokines would be 
lost, this a rgument  suggests that OA carti lage 
explants should respond less well to TNF~ than 
NA explants. This suggestion is not born out by the 
results. Overall a significantly greater proport ion 
of OA explants responded to TNF~ than NA 
explants, confirming earl ier findings that pooled 
carti lage explants from OA patients exhibited 
enhanced response to TNF~ as compared with 
explants from NA subjects [18]. An additional 
argument against the idea that the regional 
variations are due to variable loss of the 
superficial zone can be drawn from the fact that 
variations were found regardless of whether the 
explants were taken from the medial or lateral side 
of the cartilage, despite the fact that most of the 
patients were suffering from medial OA. Finally 
similar regional variations were observed with 
explants from NA subjects albeit on a limited 
number of individuals. Unfortunately no more 
carti lage specimens from NA subjects were 
available during the period of study. 
It was found that not only did TNF~.-induced 
GAG loss vary in different regions from the same 
knee, but there was some variat ion between 
explants from the same region in different knees. 
Although in total 48 explants in replicates of six 
were tested, the carti lage was obtained from only 
11 individuals (eight OA, three NA). We do not 
therefore consider it possible to judge from these 
results whether explants from a specific region of 
knee joints was more susceptible to TNF~ than any 
other. 
The results show that a concentrat ion of 
10 ng/ml TNF~ can consistently stimulate GAG 
436 Webb et al.: Differential susceptibility of human articular cartilage to TNF~ 
release from cart i lage explants over a 14 day 
period. It may be asked if the concentrat ions of 
TNF~ attained in OA joints are likely to reach 
this level. As a first step towards addressing this 
question we have taken 24 h culture supernatants  
from OA synovial membranes and measured TNF~ 
concentrations. Work to be publ ished elsewhere 
shows that  of 35 OA membranes tested, several 
attained concentrat ions between 1 and 5 ng/ml 
over this t ime period. It  remains to determine if 
similar concentrat ions of TNF~ stimulate GAG 
release from human art icular  carti lage. 
Variat ions were found both in the proport ion of 
chondrocytes expressing TNF-R and the number 
of TNF-R/chondrocyte between chondrocytes from 
different regions. It  should be noted that  no 
relat ionship could be demonstrated between the 
viabil ity of the chondrocytes before analysis and 
TNF-R expression, and that  therefore var iat ions 
in viabil ity between chondrocyte preparat ions 
cannot explain the regional  var iat ion in receptor 
expression. Do the levels of chondrocyte TNF-Rs 
determine whether cart i lage explants can respond 
to TNF? p55 TNF-R was suggested to be the major 
signal t randucing molecule for TNF~ [28]. I f  this is 
true for chondrocytes, it would be predicted that  
those in cart i lage explants from sites that respond 
to TNF~ should express more p55 TNF-R than 
those in explants from sites which failed to 
respond. The results do indeed satisfy these 
predictions, p55 but not p75 TNF-R expression 
on chondrocytes was closely related to the 
susceptibi l ity of explants from the same site to 
TNF~ induced GAG loss. This relat ionship held 
regardless of whether the data from OA and NA 
cart i lage was analysed separately or combined. 
Taken together these results are consistent 
with the notion that if sufficient TNF~ is present, 
only cart i lage from those locations at which 
chondrocytes express high numbers of TNF-R will 
degrade. Thus these results suggest a mechanism 
by which focal loss of cart i lage may occur in OA. 
The results raise the question of how chondro- 
cytes from different sites within joints vary in the 
levels of p55 TNF-R expression. One possibil ity is 
that var iat ion in mechanical  oading across the 
joint results in differential expression of cytokine 
receptors. This possibi l ity gains credence from 
evidence of var iat ions in susceptibi ly to IL-1 
between chondrocytes from differently loaded 
joints: chondrocytes from normal human ankles 
were more resistant to IL-1 than those from 
knees of the same donors (H.J. Hfiuselmann, 
personal communication).  It is well documented 
that alterations in mechanical  loading change 
chondrocyte metabolism. For example, immobiliz- 
at ion of the knee results in a marked reduction 
in proteoglycan synthesis compared with the 
contra latera l  knee [29]. Different sites within a 
joint do vary in load-bearing [30] but to our 
knowledge there is no information regarding how 
load-bearing affects the expression of chondrocyte 
catabol ic cytokine receptors. However,  sheer 
stress can induce IL-6 mRNA expression in NA 
chondrocytes [31] and we have found that  IL-6 can 
increase the expression of chondrocyte TNF-R [32]. 
Thus pathways by which mechanical  loading can 
alter catabol ic cytokine receptor expression may 
exist. 
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